Pharma Data Mining Restriction Options Available
The PDRP "enables physicians to ‘opt out’ of such disclosure quickly and easily, while still allowing their data to be available for academic and governmental research," the AMA statement said.
“We believe the PDRP balances individual physician concerns regarding prescription data with First Amendment freedoms and the fundamental public interest in robust medical research."
Mello and Messing said the Supreme Court decision "may offer an unexpected dividend to opponents of data mining: The surrounding publicity might alert physicians to their right to opt out of sharing their prescribing information through the PDRP."
Cheryl Clark is senior quality editor and California correspondent for HealthLeaders Media. She is a member of the Association of Health Care Journalists.
- 3 Favorite Nursing Trends of 2013
- Hospital Compare Adds Infection, Stroke, Readmissions Data
- SGR Bill's Payment Transparency Provision Elicits Concern
- Intelligence Report: Cost-Containment Expertise
- ICD-10: Minimizing the Financial Hit
- 7 Signs Providers Are Opening Up About Bad Healthcare Outcomes
- Premier: ACOs Poised for Growth
- SGR Repeal Bill Holds Extra Promise for Rural Hospitals
- HIT in 2014: Portal Perils and Half-Built Houses
- HL20: David Green—Disruptive Innovator Touches Millions of Lives